JAMA Network JAMA Dermatology : Skin Cancer Surveillance Program for Solid Organ Transplant Recipients
8 snips
Oct 15, 2025 David S. Lee, MD, a board-certified dermatologist and Regional Transplant Dermatology Lead at Kaiser Permanente Northern California, discusses critical insights into skin cancer risks for solid organ transplant recipients. He explains why these patients face higher rates of skin cancer and the importance of tailored screening. Dr. Lee highlights the KP SunTrack program, revealing how it improves detection rates without increasing healthcare utilization. Future steps include refining the approach with AI and emphasizing shared decision-making in patient care.
AI Snips
Chapters
Transcript
Episode notes
SunTrack Risk Stratifies Transplant Patients
- SunTrack stratifies transplant recipients into low, medium, high, and very high risk using five clinical factors.
- The tool is simple, free, and usable at the bedside to estimate individualized post-transplant skin cancer risk.
Clinical Observation Sparked The Study
- David Lee recounts noticing many transplant patients screened annually who never developed skin cancer.
- That observation within Kaiser Permanente prompted deeper study of variable risk in this population.
Automate Risk-Based Outreach And Screening
- Implement automated EHR-based risk assignment and proactive outreach to schedule annual total-body exams for high-risk transplant recipients.
- For low/medium risk patients, use primary care annual screening with rapid dermatology referral pathways.